Active, not recruitingNot applicableNCT03635424
Medtronic Transcatheter Aortic Valve Replacement (TAVR) Low Risk Bicuspid Study
Studying Familial bicuspid aortic valve
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Medtronic Cardiovascular
- Principal Investigator
- Michael Reardon, MDThe Methodist Hospital Research Institute
- Intervention
- Medtronic TAVR Systems(device)
- Enrollment
- 150 enrolled
- Eligibility
- 60 years · All sexes
- Timeline
- 2018 – 2030
Study locations (25)
- Abrazo Arizona Heart Hospital, Phoenix, Arizona, United States
- Scripps Memorial Hospital La Jolla, La Jolla, California, United States
- Los Robles Hospital & Medical Center, Thousand Oaks, California, United States
- Yale New Haven Hospital, New Haven, Connecticut, United States
- Morton Plant Hospital, Clearwater, Florida, United States
- HealthPark Medical Center, Fort Myers, Florida, United States
- Tallahassee Memorial Hospital, Tallahassee, Florida, United States
- Piedmont Atlanta Hospital, Atlanta, Georgia, United States
- Mercy Medical Center - Des Moines, Des Moines, Iowa, United States
- Massachusetts General Hospital, Boston, Massachusetts, United States
- Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
- University of Michigan Health System, Ann Arbor, Michigan, United States
- Spectrum Health Hospital, Grand Rapids, Michigan, United States
- Abbott Northwestern Hospital, Minneapolis, Minnesota, United States
- North Shore University Hospital, Manhasset, New York, United States
- +10 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03635424 on ClinicalTrials.govOther trials for Familial bicuspid aortic valve
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT06869954Towards a More Standardized Bicuspid Aortic Valve Repair: Rationale and Design of CONTOUR Trial - a Randomized TrialUniversity Hospital Augsburg
- RECRUITINGNCT06830499Sapien 3 Transcatheter Aortic Valve Replacement in Young Aortic Valve Stenosis Patients From ChinaXijing Hospital
- RECRUITINGNANCT06817148Bicuspid Aortic Valve Replacement: Evaluation of Transcatheter Versus Surgery-Pilot TrialCedars-Sinai Medical Center
- RECRUITINGNCT06802016A Study of Chinese Congenital Bicuspid Aortic ValveRuijin Hospital
- RECRUITINGNCT06657911Size Up Bicuspid with the LIra MEthod: the SUBLIME StudyIRCCS San Raffaele
- RECRUITINGNANCT06688448Valvular Assessment of New Generation Aortic Replacement DevicesInstituto Dante Pazzanese de Cardiologia
- RECRUITINGNCT06153407Genetic Test Based Risk Prediction of Early Calcific Aortic Valve Disease in Patients With Bicuspid Aortic ValveYonsei University
- ENROLLING BY INVITATIONNCT06212050Feasibility, Safety, and Effectiveness of the ACURATE neo2 Transcatheter Heart Valve for Severe Bicuspid Aortic StenosisNational University of Ireland, Galway, Ireland